{
  "success": true,
  "sourceFile": "..\\..\\..\\Downloads\\NCT07052682_SAP_001.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30
  ],
  "modelUsed": "claude-opus-4-5",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Analysis Set",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "label": "Screened",
        "description": "All participants who have signed informed consent(s)",
        "criteria": "Signed informed consent(s)"
      },
      {
        "id": "pop_2",
        "name": "All Enrolled Analysis Set",
        "populationType": "Other",
        "instanceType": "AnalysisPopulation",
        "label": "All Enrolled",
        "description": "All participants who are enrolled (as defined in Section 5.6 of the protocol) in the study",
        "criteria": "Enrolled in the study"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FAS",
        "description": "All participants who are enrolled in the study, have received at least 1 dose of study drug, and have at least 1 valid postbaseline assessment",
        "criteria": "Enrolled, received at least 1 dose of study drug, and have at least 1 valid postbaseline assessment"
      },
      {
        "id": "pop_4",
        "name": "Per-Protocol Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PPAS",
        "description": "A subset of the FAS and will include all participants who did not have any important protocol deviations affecting the efficacy evaluations",
        "criteria": "FAS participants without important protocol deviations affecting efficacy evaluations"
      },
      {
        "id": "pop_5",
        "name": "Safety Analysis Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "Safety",
        "description": "All participants who are enrolled in the study and have received at least 1 dose of study drug",
        "criteria": "Enrolled and received at least 1 dose of study drug"
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "Pharmacokinetic",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "description": "All participants in the safety analysis set who have at least 1 evaluable postdose PK concentration value",
        "criteria": "Safety analysis set participants with at least 1 evaluable postdose PK concentration value"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Demographics",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Demographic characteristics at baseline"
      },
      {
        "id": "char_2",
        "name": "Baseline Characteristics",
        "dataType": "Mixed",
        "instanceType": "Characteristic",
        "description": "Baseline characteristics including disease-related parameters"
      },
      {
        "id": "char_3",
        "name": "Medical History and Concurrent Medical Conditions",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Medical history and concurrent medical conditions"
      },
      {
        "id": "char_4",
        "name": "Medication History and Concomitant Medications",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Prior and concomitant medications"
      },
      {
        "id": "char_5",
        "name": "Pro-C3",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Neoepitope-specific N-terminal propeptide of type III collagen at baseline"
      },
      {
        "id": "char_6",
        "name": "ELF",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Enhanced Liver Fibrosis test score at baseline"
      },
      {
        "id": "char_7",
        "name": "Liver cT1 MRI",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Iron-corrected T1 mapping by magnetic resonance imaging at baseline"
      },
      {
        "id": "char_8",
        "name": "Fibrosis Stage",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "NASH CRN fibrosis stage (F1 through F4cc)"
      },
      {
        "id": "char_9",
        "name": "NAS",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Nonalcoholic Fatty Liver Disease Activity Score at baseline"
      },
      {
        "id": "char_10",
        "name": "ALT",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Alanine aminotransferase at baseline"
      },
      {
        "id": "char_11",
        "name": "AST",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Aspartate aminotransferase at baseline"
      },
      {
        "id": "char_12",
        "name": "Liver Stiffness Measurement",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Liver stiffness measurement by FibroScan at baseline"
      },
      {
        "id": "char_13",
        "name": "FIB-4",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Fibrosis-4 Index at baseline"
      }
    ],
    "summary": {
      "populationCount": 6,
      "characteristicCount": 13
    }
  }
}